Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
Artificial intelligence is one of the most fascinating and powerful technological advances to come along over the past decade. The idea that we can use ...
10 Best AI Stocks under $50 While the Covid-19 pandemic has taken a toll on many sectors worldwide, the Artificial Intelligence (AI) industry continued to thrive despite the downturn amid rising sales, adoption of AI technology across businesses, and growing demand for the use of technology in easing COVID-19’s propagation. In a survey from consulting firm Deloitte in 2020, 68% of the respondents invested more than $20 million in Artificial Intelligence. Roughly 81% of the respondents posted a positive return on AI investments in 2 years. Artificial Intelligence is one of the world’s fast...
About Actuate Therapeutics Actuate Therapeutics, Inc. is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics for cancers and inflammatory diseases. For additional information, please visit the company's website at http://www.actuatetherapeutics.com. About Lantern Pharma Lantern Pharma (Nasdaq: LTRN) is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR ® A.I. platform and machine learning to discover biomarker signatures that identify patients most likely to respond to its pipeline of gen...
Share this article DALLAS, April 26, 2021 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery and development, and identify patients who will benefit from its portfolio of targeted oncology therapeutics, announced today that it will host a conference call and live webcast on Monday, May 3, 2021 at 4:30 p.m. Eastern Time to discuss financial and operating results for the first quarter ended March 31, 2021. The call will be led by Panna Sharma, President and C...